CNS Pharmaceuticals Inc (CNSP.O)

+ 收藏

财务摘要(报告期)(CNS Pharmaceuticals Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报
每股指标:
 每股收益EPS基本(元) 会员可见会员可见会员可见会员可见-22.08-0.41
 每股净资产(元) 会员可见会员可见会员可见会员可见-2.97-0.42
 每股经营现金净流量(元) 会员可见会员可见会员可见会员可见-3.36-0.30
 每股现金流量净额(元) 会员可见会员可见会员可见会员可见0.650.02
盈利能力:
 净资产收益率平均(%) 会员可见会员可见会员可见会员可见139.2679.99
 总资产净利率(%) 会员可见会员可见会员可见会员可见-291.38-210.89
 投入资本回报率ROIC(%) 会员可见会员可见会员可见会员可见-570.51-354.87
收益质量:
 营业利润/利润总额(%) 会员可见会员可见会员可见会员可见99.96100.00
资本结构:
 资产负债率(%) 会员可见会员可见会员可见会员可见273.88366.76
 权益乘数 会员可见会员可见会员可见会员可见-0.58-0.37
 产权比率 会员可见会员可见会员可见会员可见-1.58-1.37
 流动资产/总资产(%) 会员可见会员可见会员可见会员可见86.8896.41
 非流动资产/总资产(%) 会员可见会员可见会员可见会员可见13.123.59
 流动负债/负债合计(%) 会员可见会员可见会员可见会员可见100.00100.00
 归属母公司股东的权益/投入资本(%) 会员可见会员可见会员可见会员可见-439.15-523.92
偿债能力:
 流动比率 会员可见会员可见会员可见会员可见0.320.26
 速动比率 会员可见会员可见会员可见会员可见0.320.26
 货币资金/流动负债(%) 会员可见会员可见会员可见会员可见22.0613.38
 营业利润/流动负债(%) 会员可见会员可见会员可见会员可见-89.80-58.19
 经营活动产生的现金流量净额/流动负债(%) 会员可见会员可见会员可见会员可见-71.60-52.40
 归属母公司股东的权益/负债合计(%) 会员可见会员可见会员可见会员可见-63.49-72.73
 经营活动产生的现金流量净额/负债合计(%) 会员可见会员可见会员可见会员可见-71.60-52.40
 营业利润/负债合计(%) 会员可见会员可见会员可见会员可见-89.80-58.19
成长能力:
 总资产同比增长率(%) 会员可见会员可见会员可见会员可见-61.73-77.60
 每股净资产同比增长率(%) 会员可见会员可见会员可见会员可见-601.91-126.48
 总负债同比增长率(%) 会员可见会员可见会员可见会员可见69.1955.28
 基本每股收益同比增长率(%) 会员可见会员可见会员可见会员可见85.7384.17
 归属母公司股东的权益同比增长率(%) 会员可见会员可见会员可见会员可见-274.93-226.88
 营业利润同比增长率(%) 会员可见会员可见会员可见会员可见32.1628.05
 股东权益合计同比增长率(%) 会员可见会员可见会员可见会员可见-274.93-226.88
营运能力:
衍生指标:
 现金及现金等价物净增加额TTM(元) 会员可见会员可见会员可见会员可见-2,787,692.00-4,295,305.00
 利润总额TTM(元) 会员可见会员可见会员可见会员可见-15,973,546.00-17,464,027.00
 投入资本(元) 会员可见会员可见会员可见会员可见977,710.00845,651.00
 经营活动产生的现金流量净额TTM(元) 会员可见会员可见会员可见会员可见-10,755,122.00-12,507,496.00
 归属母公司净利润TTM(元) 会员可见会员可见会员可见会员可见-15,973,546.00-17,464,027.00

前瞻产业研究院